Joseph C Larson
Biographic Data
| ID | 5222149 |
|---|---|
| NAME | Joseph C Larson |
| GIVEN NAMES | Joseph C |
| FAMILY NAME | Larson |
| SIGNATURE | LARSON J C |
| AFFILIATIONS | Fred Hutch Cancer Center |
| ORCID | 0000-0002-3075-6138 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 0 |
Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis
Placebo Improvement in Pharmacologic Treatment of Menopausal Hot Flashes: Time Course, Duration, and Predictors
OBJECTIVES: To characterize the time course, duration of improvement, and clinical predictors of placebo response in treatment of menopausal hot flashes. METHODS: Data were pooled from two trials conducted in the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network, providing a combined placebo group (n = 247) and a combined active treatment group (n = 297). Participants recorded hot flash frequency in diaries twice daily…
Placebo Adherence, Clinical Outcomes, and Mortality in the Women's Health Initiative Randomized Hormone Therapy Trials
BACKGROUND: Medication adherence may be a proxy for healthy behaviors and other factors that affect outcomes. Prior studies of the association between placebo adherence and health outcomes have been limited primarily to men enrolled in clinical trials and cardiovascular disease outcomes. We examined associations between adherence to placebo and the risk of fracture, coronary heart disease, cancer, and all-cause mortality in the 2 Women's Health I…
No prominent works on this page.
Placebo Adherence, Clinical Outcomes, and Mortality in the Women's Health Initiative Randomized Hormone Therapy Trials
BACKGROUND: Medication adherence may be a proxy for healthy behaviors and other factors that affect outcomes. Prior studies of the association between placebo adherence and health outcomes have been limited primarily to men enrolled in clinical trials and cardiovascular disease outcomes. We examined associations between adherence to placebo and the risk of fracture, coronary heart disease, cancer, and all-cause mortality in the 2 Women's Health I…
Placebo Improvement in Pharmacologic Treatment of Menopausal Hot Flashes: Time Course, Duration, and Predictors
OBJECTIVES: To characterize the time course, duration of improvement, and clinical predictors of placebo response in treatment of menopausal hot flashes. METHODS: Data were pooled from two trials conducted in the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network, providing a combined placebo group (n = 247) and a combined active treatment group (n = 297). Participants recorded hot flash frequency in diaries twice daily…
Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis
Medicine (3 works) · Clinical trial (2 works) · Confidence interval (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Menopause: Health Impacts and Treatments (2 works) · Pain Management and Placebo Effect (2 works) · Placebo (2 works) · Randomized controlled trial (2 works) · Biosimilars and Bioanalytical Methods (1 works)